BACKGROUND To compare the efficacy and safety of right internal jugular vein (IJV) approach and right innominate vein (INV) approach for US-guided totally implantable venous access devices (TIVADs), and to explore the advantages and disadvantages of the two approaches. METHODS Six hundred and nineteen adult patients had long-term infusion and chemotherapy needs and inconvenience of peripheral venous infusion. Right INV approach was used to implant 339 cases of TIVADs, and right IJV approach was used to implant 280 cases of TIVADs. The success rate of one-time catheterization and the incidence of complications in the two groups were retrospectively analyzed. RESULTS All patients were successfully implanted in TIVAD. The success rates of one-time puncture in INV group and IJV approach group were 98.53% (334/339) and 95.36% (267/280), respectively. There was significant difference between the two groups (P = 0.020). The incidence of perioperative complications and long-term complications in the right INV group were 1.18% (4/339) and 3.54% (12/339), respectively, while those in the right IJV group were 1.43% (4280) and 3.93% (11280). There was no significant difference in the incidence of perioperative or long-term complications between the two groups (P = 0.785, P = 0.799, respectively). CONCLUSIONS US-guided TIVADs via the right INV approach and the right IJV approach are both safe and reliable. The right INV approach improves the one-time puncture success rate, as long as the technique is properly operated, serious complications rarely occur.

中文翻译：

---

超声引导下经右无名静脉和右颈内静脉入路 TIVAD 的比较。


背景比较右颈内静脉(IJV)入路和右无名静脉(INV)入路超声引导下完全植入式静脉通路装置(TIVAD)的有效性和安全性，探讨两种入路的优缺点。方法619例有长期输液、化疗需要且外周静脉输液不便的成年患者。采用右INV入路植入TIVAD 339例，采用右IJV入路植入TIVAD 280例。回顾性分析两组一次性导尿成功率及并发症发生情况。结果所有患者均成功植入TIVAD。 INV组和IJV入路组一次性穿刺成功率分别为98.53%（334/339）和95.36%（267/280）。两组之间有显着性差异（P = 0.020）。右INV组围手术期并发症和远期并发症发生率分别为1.18%（4/339）和3.54%（12/339），右IJV组围手术期并发症和远期并发症发生率分别为1.43%（4280）和3.93% （11280）。两组围手术期或远期并发症发生率无显着差异（分别为P=0.785、P=0.799）。结论 通过正确的 INV 方法和正确的 IJV 方法，美国引导的 TIVAD 既安全又可靠。正确的INV入路可提高一次性穿刺成功率，只要操作得当，很少发生严重并发症。